Gabriele Luigi Gasparini

Gabriele Luigi Gasparini

Auto-generated profile, based on publicly available information

Gabriele Luigi Gasparini

Cardio Center IRCCS Humanitas Research Hospital Rozzano‐Milan Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
MGMauro Gitto
Mauro Gitto
ASAlessandro Sticchi
Alessandro Sticchi
MCMauro Chiarito
Mauro Chiarito
LNLaura Novelli
Laura Novelli
PLPier Pasquale Leone
Pier Pasquale Leone
ACAntonio Colombo
Antonio Colombo
BACKGROUND: Drug-coated balloons (DCB) are an emerging tool for modern percutaneous coronary intervention (PCI), but evidence on their use for de novo lesions on large vessels is limited. METHODS: Consecutive patients undergoing DCB-based PCI on the left anterior descending artery in 2 Italian centers from 2018 to 2022 were retrospectively enrolled and compared with patients who received left anterior descending PCI with contemporary drug-eluting stents (DES). In-stent restenosis was excluded. The DCB group included both patients undergoing DCB-only PCI and those receiving hybrid PCI with DCB and DES combined. The primary end point was target lesion failure at 2 years, defined as the composite of target lesion revascularization, cardiac death, and target vessel myocardial infarction. RESULTS: We included 147 consecutive patients undergoing DCB-based treatment on the left anterior descending artery and compared them to 701 patients who received conventional PCI with DES. In the DCB group, 43 patients (29.2%) were treated with DCB only and 104 (70.8%) with a hybrid approach; DCB length was greater than stent length in 55.1% of cases. Total treated length was higher in the DCB group (65 [40–82] versus 56 [46–66] mm; P =0.002), while longer DESs were implanted (38 [24–62] versus 56 [46–66] mm; P <0.001) and a higher rate of large vessels were treated (76.2% versus 83.5%; P =0.036) in the DES cohort. The cumulative 2-year target lesion failure incidence was not significantly different between the 2 groups (DCB, 4.1% versus DES, 9.8%; hazard ratio, 0.51 [95% CI, 0.20–1.27]; P =0.15). After a 1:1 propensity score matching resulting in 139 matched pairs, the DCB-based treatment was associated with a lower risk for target lesion failure at 2 years compared with DES-only PCI (hazard ratio, 0.2 [95% CI, 0.07–0.58]; P =0.003), mainly driven by less target lesion revascularization. CONCLUSIONS: A DCB-based treatment approach for left anterior descending revascularization allows a significantly reduced stent burden, thereby potentially limiting target lesion failure risk at midterm follow-up.

21 March 2022 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
JSJorge Sanz-Sánchez
Jorge Sanz-Sánchez
KMKambis Mashayekhi
Kambis Mashayekhi
PAPierfrancesco Agostoni
Pierfrancesco Agostoni
MEMohaned Egred
Mohaned Egred
AAAlexandre Avran
Alexandre Avran
GGGabriele L. Gasparini
Gabriele L. Gasparini
Introduction: Device entrapment is a life‐threatening complication during percutaneous coronary intervention (PCI). However, the success for its management is predominantly based on operator experience with limited available guidance in the published literature.Methods: A systematic review was performed on December 2021; we searched PubMed for articles on device entrapment during PCI. In addition, backward snowballing (i.e., review of references from identified articles and pertinent reviews) was employed.Results: A total of 4209 articles were retrieved, of which 150 studies were included in the synthesis of the data. A methodical algorithmic approach to prevention and management of device entrapment can help to optimize outcomes. The recommended sequence of steps are as follows: (a) pulling, (b) trapping, (c) snaring, (d) plaque modification, (e) telescoping, and (f) surgery.Conclusions: In‐depth knowledge of the techniques and necessary tools can help optimize the likelihood of successful equipment retrieval and minimization of complications.

1 April 2018 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
JOJacopo A. Oreglia
Jacopo A. Oreglia
RGRoberto Garbo
Roberto Garbo
AGAndrea Gagnor
Andrea Gagnor
GGGabriele L. Gasparini
Gabriele L. Gasparini

29 July 2016 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
RGRoberto Garbo
Roberto Garbo
JOJacopo A. Oreglia
Jacopo A. Oreglia
GGGabriele L. Gasparini
Gabriele L. Gasparini

7 November 2023 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
OCOttavia Cozzi
Ottavia Cozzi
MMMatteo Maurina
Matteo Maurina
MCMichele Cacia
Michele Cacia
VBValentina Bernardini
Valentina Bernardini
AGAisha Gohar
Aisha Gohar
DRDamiano Regazzoli
Damiano Regazzoli
Background: Percutaneous treatment for ostial left circumflex artery (LCx) lesions is known to be associated with suboptimal results.Aims: The present study aims to assess the procedural and long‐term clinical outcomes of percutaneous coronary intervention (PCI) for de novo ostial LCx lesions overall and according to the coronary revascularization strategy.Methods: Consecutive patients undergoing PCI with second generation drug eluting stents or drug coated balloons for de novo ostial LCx lesions in three high‐volume Italian centers between 2012 and 2021 were retrospectively evaluated. The primary endpoint was target‐vessel revascularization (TVR) at 2 years. Secondary endpoints included major adverse cardiovascular and cerebrovascular events (MACCE), target lesion revascularization, myocardial infarction, stroke, all‐cause death, and repeat revascularization.Results: A total of 366 patients were included in the analysis with a median follow‐up of 901 (IQR: 450−1728) days. 79.5% of the patients were male, 33.6% were diabetic, 49.7% had a previous PCI, and 23.1% a prior surgical revascularization. Very ostial LCx stenting was performed in 34.1%, crossover from left main to LCx in 17.3%, and a two‐stent strategy in 48.6% of cases, respectively. In the overall population, the incidence of TVR at 2 years was 19.0% while MACCE rate was 25.7%. No major differences in clinical outcomes were found according to the stenting strategy. Use of intracoronary imaging was associated with fewer MACCE (HR: 0.47, 95% CI: 0.25−1.13, p = 0.01), while the diameter of the stent implanted in the ostial LCx was associated with less TVR (HR: 0.43, 95% CI: 0.25−0.75, p = 0.002).Conclusions: Percutaneous revascularization of the ostial LCx is associated with a high rate of TVR, regardless of the stenting strategy. Intracoronary imaging and proper stent sizing may reduce the failure rates.

1 October 2018 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
GGGabriele L. Gasparini
Gabriele L. Gasparini
PMPIERLUIGI MERELLA
PIERLUIGI MERELLA
PMPietro Mazzarotto
Pietro Mazzarotto
AGAndrea Gagnor
Andrea Gagnor
RGRoberto Garbo
Roberto Garbo
JOJacopo A. Oreglia
Jacopo A. Oreglia